
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Land Rover Just Unveiled Its Dakar Rally Defender - 2
7 Heavenly Espressos, One Do You Like? - 3
A Gustav Klimt painting is now the most expensive piece of modern art sold at auction. The fascinating history behind the $236 million 'Portrait of Elisabeth Lederer.' - 4
Figuring out the Business venture Code: The Response to Building an Effective Startup - 5
Satellite observations offer insight into a tsunami's early stages
The Most Astonishing Arising Advancements to Watch
I thought I knew the night sky, but what I saw from the Canary Islands left me speechless
Venice’s newest marvel is a wild, acrobatic dolphin. His refusal to leave puts him in danger
The Force of Systems administration: Individual Examples of overcoming adversity
This Is Canada's Only Province Without Any Bears
Manual for 6 famous sorts of cheddar
What to know about the hepatitis B shot — and why Trump officials are targeting it
How much should a kid's birthday party cost? One mom spent $190 for pizza and ice cream at a park. Another paid $2K for a playspace and goodie bags.
Zelensky sees win for Ukraine as EU finally reaches funding deal













